Indications -- Psoriasis/Chronic Inflammation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Indications -- Psoriasis/Chronic Inflammation

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (251)	7/30/2002 2:01:47 PM
From: keokalani'nui	of 631

>>Celltech deserves better news<< Couldn't agree more. Though it doesn't sound like you would be in favor, maybe they will redirect resources to x870. It would be hard to give up in total considering safety profile and teasingly meaningful efficacy. Still, they had enough patients to have convincing results and didn't. Maybe one more trial, single dose, 10 day assessment. Sh@@t, what do I know.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next